Resultados globales: 6 registros encontrados en 0.02 segundos.
Artículos, Encontrados 6 registros
Artículos Encontrados 6 registros  
1.
5 p, 332.1 KB Biosimilars : a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers / Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Vyas, Malvika (European Society for Medical Oncology) ; Giuliani, Rosa (San Camillo Forlanini Hospital) ; Arnold, Dirk (CUF Hospitals) ; Cardoso, Fatima (Champalimaud Clinical Center) ; Casali, Paolo Giovanni (Fondazione IRCCS National Cancer Institute) ; Cervantes, Andrés (Clinic Hospital) ; Eggermont, Alexander (Gustave Roussy Cancer Campus Grand Paris) ; Eniu, Alexandru (Cancer Institute "Ion Chiricuta") ; Jassem, Jacek (Medical University of Gdansk) ; Pentheroudakis, George (University of Ioannina) ; Peters, Solange (Centre Hospitalier Universitaire Vaudois) ; Rauh, Stefan (Hospital Center Emile Mayrisch) ; Zielinski, Christoph C. (Medical University of Vienna) ; Stahel, Rolf A. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Voest, Emile (University Hospital Zurich (Suïssa)) ; Douillard, Jean-Yves (European Society for Medical Oncology) ; McGregor, Keith (European Society for Medical Oncology) ; Ciardiello, Fortunato (Second University of Naples) ; Universitat Autònoma de Barcelona
Biosimilars present a necessary and timely opportunity for physicians, patients and healthcare systems. If suitably developed clinically, manufactured to the correct standards and used appropriately, they can positively impact on the financial sustainability of healthcare systems. [...]
2017 - 10.1136/esmoopen-2016-000142
ESMO open, Vol. 1 (january 2017)  
2.
5 p, 637.4 KB Educational needs in gastrointestinal cancer : a consensus position paper from the ESMO Gastrointestinal Cancer Faculty / Lordick, Florian (Leipzig University Medical Center) ; Obermannova, Radka (Masaryk University) ; Vola, Doris (European Society for Medical Oncology) ; Douillard, Jean-Yves (European Society for Medical Oncology) ; Mcgregor, Keith (European Society for Medical Oncology) ; Van Cutsem, Eric (University Hospitals Leuven (Bèlgica)) ; Tabernero, Josep (Universitat Autònoma de Barcelona) ; Ciardiello, Fortunato (Second University of Naples) ; Cervantes, Andrés (Universitat de València)
Gastrointestinal (GI) cancers are common in all parts of the world. Effective prevention and early detection of GI cancers are not universally implemented. Therefore, it must be anticipated that the incidence and the mortality of GI cancers will remain high within the next decades. [...]
2019 - 10.1136/esmoopen-2019-000533
ESMO open, Vol. 4 (july 2019)  
3.
18 p, 451.1 KB EHA evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for haematological malignancies / Kiesewetter, B. (Department of Medicine i. Clinical Division of Oncology. Medical University of Vienna) ; Cherny, N. I. (Cancer Pain and Palliative Medicine Service. Department of Medical Oncology. Shaare Zedek Medical Center) ; Boissel, Nicolas (Diderot University Paris Faculty of Medicine) ; Cerisoli, F. (European Hematology Association) ; Dafni, U. (Frontier Science Foundation-Hellas) ; De Vries, Elisabeth G. E. (Department of Medical Oncology. University Medical Center Groningen) ; Ghia, Paolo (Universita Vita e Salute San Raffaele) ; Gökbuget, N. (Department of Hematology/Oncology. Goethe University) ; González-Calle, Verónica (Instituto de Investigación Biomédica de Salamanca) ; Huntly, B. (Cambridge Stem Cell Institute. Department of Haematology. University of Cambridge) ; Jäger, U. (Department of Medicine i. Clinical Division of Hematology and Hemostaseology. Medical University of Vienna) ; Latino, N. J. (Head Office. European Society for Medical Oncology) ; Douillard, Jean-Yves (Head Office. European Society for Medical Oncology) ; Malcovati, Luca (Department of Hematology Oncology. Fondazione IRCCS Policlinico San Matteo) ; Mateos, M. V. (Instituto de Investigación Biomédica de Salamanca) ; Ossenkoppele, G. J. (Amsterdam Universitair Medische Centra (Amsterdam, Països Baixos)) ; Porkka, K. (Helsinki University Hospital (Finlàndia)) ; Raderer, M. (Department of Medicine i. Clinical Division of Oncology. Medical University of Vienna) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Scarfò, Lydia (Universita Vita e Salute San Raffaele) ; Wester, R. (Erasmus MC Cancer Institute (Rotterdam, Països Baixos)) ; Zygoura, P. (Frontier Science Foundation-Hellas) ; Sonneveld, P. (Department of Radiation Oncology. Erasmus MC Cancer Institute) ; Universitat Autònoma de Barcelona
Objective Value frameworks in oncology have not been validated for the assessment of treatments in haematological malignancies, but to avoid overlaps and duplications it appears reasonable to build up experience on existing value frameworks, such as the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS). [...]
2020 - 10.1136/esmoopen-2019-000611
ESMO open, Vol. 5 Núm. 1 (20 2020) , p. e000611  
4.
7 p, 242.6 KB Primary tumor sidedness has an impact on prognosis and treatment outcome in metastatic colorectal cancer : results from two randomized first-line panitumumab studies / Boeckx, N. (University Hospital Antwerp (Bèlgica)) ; Koukakis, R. (Biostatistics, Amgen Ltd) ; Op de Beeck, K. (University Hospital Antwerp (Bèlgica)) ; Rolfo, Christian (University Hospital Antwerp (Bèlgica)) ; Van Camp, G. (University Hospital Antwerp (Bèlgica)) ; Siena, S. (Dipartimento di Oncologia e Emato-Oncologia, Università degli Studi di Milano) ; Tabernero, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ; Douillard, Jean-Yves (Medical Oncology, Institut de Cancérologie de l'Ouest (ICO) René Gauducheau, Nantes, France) ; André, Thierry (Department of Medical Oncology, Hôpital Saint Antoine; Sorbonne Universités, UMPC Paris 06 and GERCOR, Paris, France) ; Peeters, Marc (University Hospital Antwerp (Bèlgica))
Previous studies have reported the prognostic impact of primary tumor sidedness in metastatic colorectal cancer (mCRC) and its influence on cetuximab efficacy. The present retrospective analysis of two panitumumab trials investigated a possible association between tumor sidedness and treatment efficacy in first-line mCRC patients with RAS wild-type (WT) primary tumors. [...]
2017 - 10.1093/annonc/mdx119
Annals of oncology, Vol. 28 (april 2017) , p. 1862-1868  
5.
10 p, 1016.0 KB Global cancer control : responding to the growing burden, rising costs and inequalities in access / Prager, Gerald W. (Medical University of Vienna) ; Braga, Sofia (Instituto CUF Oncologia) ; Bystricky, Branislav (Faculty Hospital Trencin) ; Qvortrup, Camilla (Odense University Hospital (Dinamarca)) ; Criscitiello, Carmen (Istituto Europeo di Oncologia) ; Esin, Ece (Ankara Oncology Education and Research Hospital) ; Sonke, Gabe S. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Argilés Martínez, Guillem (Vall d'Hebron Institut d'Oncologia) ; Frenel, Jean-Sebastian (Institut de Cancerologie de l'Ouest Saint-Herblain) ; Karamouzis, Michalis (National and Kapodistrian University of Athens) ; Strijbos, Michiel (AZ KLINA Hospitals) ; Yazici, Ozan (Ankara Numune Education and Research Hospital) ; Bossi, Paolo (Fondazione IRCCS Istituto Nazionale Tumori Milano) ; Banerjee, Susana (Royal Marsden Hospital (Regne Unit)) ; Troiani, Teresa (Università degli Studi della Campania Luigi Vanvitelli) ; Eniu, Alexandru (Cancer Institute "Ion Chiricuta") ; Ciardiello, Fortunato (Università degli Studi della Campania Luigi Vanvitelli) ; Tabernero, Josep (Universitat Autònoma de Barcelona. Departament de Medicina) ; Zielinski, Christoph C. (Medical University Vienna, General Hospital, and Vienna Cancer Center) ; Casali, Paolo Giovanni (Istituto Nazionale Tumori) ; Cardoso, Fatima (Champalimaud Clinical Center) ; Douillard, Jean-Yves (European Society for Medical Oncology) ; Jezdic, Svetlana (European Society for Medical Oncology) ; McGregor, Keith (European Society for Medical Oncology) ; Bricalli, Gracemarie (European Society for Medical Oncology) ; Vyas, Malvika (European Society for Medical Oncology) ; Ilbawi, André (Disability, Violence and Injury Prevention (NVI), World Health Organization)
The cancer burden is rising globally, exerting significant strain on populations and health systems at all income levels. In May 2017, world governments made a commitment to further invest in cancer control as a public health priority, passing the World Health Assembly Resolution 70. [...]
2018 - 10.1136/esmoopen-2017-000285
ESMO open, Vol. 3 (february 2018)  
6.
7 p, 814.0 KB Quality of life during first-line FOLFOX4±panitumumab in RAS wild-type metastatic colorectal carcinoma : results from a randomised controlled trial / Siena, Salvatore (Università degli Studi di Milano (Italy)) ; Tabernero, Josep (Vall d'Hebron Institut d'Oncologia) ; Bodoky, Gyorgy (St László Hospital (Hongria)) ; Cunningham, David (Royal Marsden National Health Service Foundation Trust (United Kingdom)) ; Rivera, Fernando (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Ruff, Paul (University of the Witwatersrand (South Africa)) ; Canon, Jean Luc (Grand Hôpital de Charleroi. Service d'Oncologie-Hématologie (Belgium)) ; Koukakis, Reija (Amgen Ltd. Department of Biostatistics (United Kingdom)) ; Demonty, Gaston (Amgen GmbH. Medical Development (Suïssa)) ; Hechmati, Guy (Amgen GmbH. Global Health Economics (Suïssa)) ; Douillard, Jean-Yves (Institut de Cancérologie de l'Ouest (France)) ; Universitat Autònoma de Barcelona
Metastatic colorectal cancer is rarely curable. Improving quality of life is therefore a key treatment goal. We report quality of life for patients with RAS wild-type metastatic colorectal cancer in the PRIME study. [...]
2016 - 10.1136/esmoopen-2016-000041
ESMO open, Vol. 1, Issue 2 (March 2016) , art. e000041  

Vea también: autores con nombres similares
8 Douillard, Jean-Yves
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.